Simplex Trading’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-92
Closed -$3K 8556
2024
Q4
$3K Buy
92
+4
+5% +$68 ﹤0.01% 7836
2024
Q3
$2K Sell
88
-87
-50% -$2.71K ﹤0.01% 7957
2024
Q2
$7K Buy
175
+95
+119% +$5.22K ﹤0.01% 7647
2024
Q1
$5K Sell
80
-52
-39% -$3.88K ﹤0.01% 7977
2023
Q4
$14K Buy
132
+39
+42% +$4.07K ﹤0.01% 7170
2023
Q3
$16K Buy
+93
New +$24.4K ﹤0.01% 6799
2023
Q2
Sell
-38
Closed -$24K 8988
2023
Q1
$24K Sell
38
-191
-83% -$170K ﹤0.01% 6707
2022
Q4
$200K Buy
229
+122
+114% +$154K ﹤0.01% 4223
2022
Q3
$117K Buy
107
+28
+35% +$37K ﹤0.01% 5291
2022
Q2
$65K Sell
79
-42
-35% -$43.2K ﹤0.01% 6142
2022
Q1
$187K Sell
121
-92
-43% -$124K ﹤0.01% 5250
2021
Q4
$382K Sell
213
-267
-56% -$714K ﹤0.01% 4198
2021
Q3
$1.96M Buy
480
+5
+1% +$17.5K ﹤0.01% 2167
2021
Q2
$2.09M Buy
475
+469
+7,817% +$1.85M ﹤0.01% 2100
2021
Q1
$2.71M Buy
+6
New +$33.8K ﹤0.01% 1301

Other funds holding BNGO

Simplex Trading's BNGO Position: Q1 2025 in Review

Simplex Trading sold out of Bionano Genomics (BNGO) in Q1 2025, closing a stake of 14 shares.

Simplex Trading first reported a position in BNGO in Q1 2021 and held it in 8 quarters. The position peaked at $2M in Q1 2021. 30 funds tracked by Wall St. Rank hold BNGO as of Q1 2025.

  • Simplex Trading reported no remaining Bionano Genomics position as of Q1 2025 after selling out during the quarter.
  • Simplex Trading sold 14 Bionano Genomics shares in Q1 2025.
  • Simplex Trading first reported a position in Bionano Genomics in Q1 2021 and held it in 8 quarters.
  • Simplex Trading's Bionano Genomics position peaked at $2M in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Bionano Genomics as of Q1 2025.

Based on Simplex Trading's 13F filing for Q1 2025, filed 12 May 2025.